Copyright
©The Author(s) 2021.
World J Hepatol. Jan 27, 2022; 14(1): 168-179
Published online Jan 27, 2022. doi: 10.4254/wjh.v14.i1.168
Published online Jan 27, 2022. doi: 10.4254/wjh.v14.i1.168
Figure 1 Schematic summary of experimental evidence on stearoyl-CoA desaturase 1 inhibition.
SCD1: Stearoyl-CoA desaturase 1; MUFA: Monounsaturated fatty acids; NAFLD: Non-alcoholic fatty liver disease; NASH: Non-alcoholic steatohepatitis; ↓: Decrease.
- Citation: Jeyakumar SM, Vajreswari A. Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence. World J Hepatol 2022; 14(1): 168-179
- URL: https://www.wjgnet.com/1948-5182/full/v14/i1/168.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i1.168